The clininical value of vascular endothelial growth factor (VEGF) in the development of lung sarcoidosis.

L. Ponomareva (Moscow, Russian Federation), E. Popova (Moscow, Russian Federation), A. Ponomarev (Moscow, Russian Federation)

Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Session: Sarcoidosis: from basic research to patient outcomes
Session type: Poster Discussion
Number: 5214
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Ponomareva (Moscow, Russian Federation), E. Popova (Moscow, Russian Federation), A. Ponomarev (Moscow, Russian Federation). The clininical value of vascular endothelial growth factor (VEGF) in the development of lung sarcoidosis.. 5214

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: